SCHEMBL16588477

SCHEMBL16588477

C=CCCCCCCCCCOP(=O)(OCCCCCCCCCC=C)Oc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 2/20 0.50
LPAR2 Q9HBW0 1/20 0.50
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PKM P14618 1/20 0.38
SRC P12931 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16581628 0.98 LPAR3 (0.47) LPAR3LPAR2ALDH1A1L3MBTL1PKM
SCHEMBL16588474 0.87 SRC (0.41) ALDH1A1L3MBTL1PKMSRC
SCHEMBL13430901 0.84 CYP3A4 (0.43)
SCHEMBL27042268 0.84 SRC (0.47) L3MBTL1PKMSRC
SCHEMBL17491620 0.84 SRC (0.47) L3MBTL1PKMSRC
SCHEMBL9818167 0.82 SRC (0.48) L3MBTL1PKMSRC
SCHEMBL16597528 0.81 SRC (0.36) ALDH1A1L3MBTL1PKMSRC
SCHEMBL13430898 0.81 CA1 (0.46) L3MBTL1
SCHEMBL19904731 0.81 MEN1 (0.45) ALDH1A1L3MBTL1PKM
SCHEMBL29262144 0.80 LTA4H (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3049502-B1 LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION MAX PLANCK GESELLSCHAFT (DE) 2020-04-01 EP disclosed
US-10400164-B2 Long-term stable photoactive composition, such as phosphorescent composition or TTA-photon upconversion composition MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2019-09-03 US disclosed
US-20160222286-A1 LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-08-04 US disclosed
US-20160222286-A1 LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2016-08-04 US disclosed
WO-2015044129-A1 LONG-TERM STABLE PHOTOACTIVE COMPOSITION, SUCH AS PHOSPHORESCENT COMPOSITION OR TTA-PHOTON UPCONVERSION COMPOSITION MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-04-02 WO disclosed
EP-2851407-A1 Long-term stable photoactive composition, such as phosphorescent composition or TTA-photon upconversion composition Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2015-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10400164-B2 Long-term stable photoactive composition, such as phosphorescent composition or TTA-photon upconversion composition TTPA, TCP1, TERB1 LPAR3 2916/4885LPAR2 3373/4885ALDH1A1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.